In vivo prediction of vascular susceptibility to vascular endothelial growth factor withdrawal: Magnetic resonance imaging of C6 rat glioma in nude mice

Cancer Research

Volumn 59, Issue 19, 1999, Pages 5012-5016

  Abramovitch, Rinat ^a   Dafni, Hagit ^a   Smouha, Eitzik ^a   Benjamin, Laura E ^b   Neeman, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLIOMA; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ACTINS; ANIMALS; ENDOTHELIAL GROWTH FACTORS; GLIOMA; LYMPHOKINES; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; RATS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASODILATION;

EID: 0033214065     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
2. Benjamin, L. E., Hemo, I., and Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development (Camb.), 125: 1591-1598, 1998.
3. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Investig., 103: 159-165, 1998.
4. Folkman, J., and D'Amore, P. A. Blood vessel formation: what is its molecular basis? Cell, 87: 1153-1155, 1996.
5. D'Amore, P. A. Capillary growth: a two-cell system. Semin. Cancer Biol., 3:49-56, 1992.
6. Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, I., Demunck, H., Kasper, M., Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T., and Collen, D. Role of tissue factor in embryonic blood vessel development. Nature (Lond.), 383: 73-75, 1996.
7. Kuo, C. T., Veselits, M. L., Barton, K. P., Lu, M. M., Clendenin, C., and Leiden, J. M. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev., 11: 2996-3006, 1997.
8. Vikkula, M., Boon, L. M., Carraway, K. L. R., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., Mulliken, J. B., and Olsen, B. R. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell, 87: 1181-1190, 1996.
9. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., and Yancopoulos, G. D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 87: 1171-1180, 1996.
10. Benjamin, L. E., and Keshet, E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA, 94: 8761-8766, 1997.
11. Ferrara, N. Vascular endothelial growth factor. Eur. J. Cancer. 32A: 2413-2422, 1996.
12. Claffey, K. P., and Robinson, G. S. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev., 15: 165-176, 1996.
13. Carmeliet, P., Moons, L., Dewerchin, M., Mackman, N., Luther, T., Breier, G., Ploplis, V., Muller, M., Nagy, A., Plow, E., Gerard, R., Edgington, T., Risau, W., and Collen, D. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann. N. Y. Acad. Sci., 811: 191-206, 1997.
14. Klagsbrun, M., and D'Amore, P. A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev., 7: 259-270, 1996.
15. Borgstrom, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
16. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
17. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
18. Abramovitch, R., Frenkiel, D., and Neeman, M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn. Reson. Med., 39: 813-824. 1998.
19. Ogawa, S., Lee, T. M., Nayak, A. S., and Glynn, P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med., 14: 68-78, 1990.
20. Griffiths, J. R., Taylor, N. J., Howe, F. A., Saunders, M. I., Robinson, S. P., Hoskin, P. J., Powell, M. E., Thoumine, M., Caine, L. A., and Baddeley, H. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys., 39: 697-701, 1997.
21. Robinson, S. P., Rodrigues, L. M., Ojugo, A. S., McSheehy, P. M., Howe, F. A., and Griffiths, J. R. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br. J. Cancer, 75: 1000-1006, 1997.
22. Kuperman, V., River, J. N., Lewis, M. Z., Lubich, L. M., and Karczmar, G. S. Changes in T2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn. Reson. Med., 33: 318-325, 1995.
23. Karczmar, G. S., River, J. N., Li, J., Vijayakumar, S., Goldman, Z., and Lewis, M. Z. Effects of hyperoxia on T2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed., 7: 3-11, 1994.
24. Carmeliet, P., Dor, Y., Herbert, J-M., Fukumara, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., and Keshet, E. Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (Lond.), 394: 485-490, 1998.
25. Torres Filho, I. P., Leunig, M., Yuan, F., Intaglietta, M., and Jain, R. K. Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc. Natl. Acad. Sci. USA, 91: 2081-2085, 1994.
26. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
27. Hirschi, K. K., and D'Amore, P. A. Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS, 79: 419-428, 1997.
28. D'Amore, P. A., and Smith, S. R. Growth factor effects on cells of the vascular wall: a survey. Growth Factors, 8: 61-75, 1993.
29. Abramovitch, R., Neeman, M., Reich, R., Stein, I., Keshet, E., Abraham, J., Solomon, A., and Marikovsky, M. Intercellular communication between vascular smooth muscle and endothelial cells mediated by HB-EGF and VEGF. FEBS Lett., 425: 441-447, 1998.
30. Lindahl, P., Hellstrom, M., Kalen, M., and Betsholtz, C. Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. Curr. Opin. Lipidol., 9: 407-411, 1998.
31. Peters, K. G. Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ. Res., 83: 342-343, 1998.
32. Goede, V., Schmidt, T., Kimmina, S., Kozian, D., and Augustin, H. G. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Investig., 78: 1385-1394, 1998.
33. Tanaka, S., Mori, M., Sakamoto, Y., Makuuchi, M., Sugimachi, K., and Wands, J. R. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J. Clin. Investig., 103: 341-345, 1999.
34. Stratmann, A., Risau, W., and Plate, K. H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol., 153: 1459-1466, 1998.
35. van Zijl, P. C., Eleff, S. M., Ulatowski, J. A., Oja, J. M., Ulug, A. M., Traystman, R. J., and Kauppinen, R. A. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat. Med., 4: 159-167, 1998.
36. Detre, J. A., Zhang, W., Roberts, D. A., Silva, A. C., Williams, D. S., Grandis, D. J., Koretsky, A. P., and Leigh, J. S. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed., 7: 75-82, 1994.